Skip to main content

Balchem Corporation Value Stock - Dividend - Research Selection

Balchem corporation

ISIN: US0576652004 , WKN: 905650

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Balchem (NASDAQ:BCPC) shareholders have earned a 9.2% CAGR over the last five years

2025-09-29
The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...

Blachem (BCPC) Moves to Buy: Rationale Behind the Upgrade

2025-09-24
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

NewMarket's Profitability Could Make It More Expensive Than Its Peers

2025-09-22
NewMarket Corporation stands out for strong profitability, consistent dividends, and operational efficiency. Read why NEU stock is a Buy.

Is Now The Time To Put Balchem (NASDAQ:BCPC) On Your Watchlist?

2025-08-30
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

H.C. Wainwright Reaffirms Buy on Balchem (BCPC), Lifts Price Target Following Strong Q2 Results

2025-08-27
Balchem Corporation (NASDAQ:BCPC) ranks among the best mid-cap materials stocks to buy now. Following the company’s second-quarter financial reports, H.C. Wainwright maintained its Buy rating on Balchem Corporation (NASDAQ:BCPC) and increased its price target from $180 to $189 on August 5. For the second quarter of 2025, Balchem Corporation (NASDAQ:BCPC) recorded revenue of $255.5 million, […]

Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

2025-08-26
MONTVALE, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem C

Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

2025-08-16
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Luxel Corporation Appoints Adrian Polliack, PhD, as President

2025-08-07
Luxel Corporation, a recognized leader in advanced materials and technology solutions, is pleased to announce the appointment of Adrian Polliack, PhD, as President, effective July 31, 2025. Dr. Polliack will oversee day-to-day management, strategic growth initiatives, and operational excellence programs. Travis Ayers, who has served as President since 2007, and remains the owner of Luxel Corporation, will transition to the role of Chief Executive Officer, continuing to guide Luxel's long-term vi

Balchem Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line

2025-08-02
Balchem ( NASDAQ:BCPC ) Second Quarter 2025 Results Key Financial Results Revenue: US$255.5m (up 9.1% from 2Q 2024...

Balchem (BCPC) Surpasses Q2 Earnings and Revenue Estimates (Revised)

2025-08-01
Balchem (BCPC) delivered earnings and revenue surprises of +1.60% and +1.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?